Description of Compliance With Hydroxychloroquine Treatment in Patients With Systemic Lupus Erythematosus in a Hospital Internal Medicine Consultation

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The project focuses on non-compliance in patients with systemic lupus erythematosus taking Plaquenil. More than half of patients with chronic illness are not or only poorly compliant with their treatment and lupus is one of them. The investigators want to use an already validated existing questionnaire in English, the Morisky Medication Adherence Scale 8 (MMAS 8). These results will make it possible, after a multivariate study with reference to the gold standard which is hydroxychloroquinemia, to see which exact questions in the questionnaire can be used in general medicine practices in order to detect less or non-compliant patients as early as possible.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 75
Healthy Volunteers: f
View:

⁃ Age \>18 years

• Patient with systemic lupus erythematosus

• Treatment with PLAQUENIL for \> 6 months with dosage of hydroxychloroquinemia planned during the consultation.

Locations
Other Locations
France
Toulouse Hospital
RECRUITING
Toulouse
Contact Information
Primary
Laurent Sailler, MD
sailler.l@chu-toulouse.fr
0561779654
Time Frame
Start Date: 2023-11-29
Estimated Completion Date: 2024-12-31
Participants
Target number of participants: 50
Treatments
The Morisky Medication Adherence Scale (MMAS-8)
The Morisky Medication Adherence Scale completed by the patients
Related Therapeutic Areas
Sponsors
Leads: University Hospital, Toulouse

This content was sourced from clinicaltrials.gov